Kadambavanasund Papavinasasundaram
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mycobacterium tuberculosis | 31 | 2025 | 384 | 3.180 |
Why?
|
| Tuberculosis | 14 | 2025 | 263 | 1.650 |
Why?
|
| Bacterial Proteins | 15 | 2025 | 749 | 1.110 |
Why?
|
| Antitubercular Agents | 7 | 2025 | 77 | 0.950 |
Why?
|
| Mycobacterium smegmatis | 7 | 2021 | 66 | 0.910 |
Why?
|
| Cell Wall | 4 | 2022 | 113 | 0.580 |
Why?
|
| Gene Deletion | 5 | 2019 | 298 | 0.540 |
Why?
|
| Macrophages | 10 | 2025 | 1004 | 0.410 |
Why?
|
| Gene Expression Regulation, Bacterial | 6 | 2025 | 149 | 0.380 |
Why?
|
| Peptidoglycan | 4 | 2021 | 54 | 0.330 |
Why?
|
| Operon | 4 | 2025 | 34 | 0.300 |
Why?
|
| Tuberculosis, Pulmonary | 4 | 2005 | 107 | 0.300 |
Why?
|
| Chromosomes, Bacterial | 2 | 2018 | 42 | 0.300 |
Why?
|
| Type VII Secretion Systems | 2 | 2025 | 8 | 0.280 |
Why?
|
| Antigens, Bacterial | 3 | 2025 | 214 | 0.270 |
Why?
|
| Iron | 2 | 2024 | 144 | 0.260 |
Why?
|
| Mice | 16 | 2025 | 10273 | 0.240 |
Why?
|
| Glucans | 1 | 2025 | 63 | 0.230 |
Why?
|
| Mycobacteriaceae | 1 | 2024 | 2 | 0.230 |
Why?
|
| Bacillus | 1 | 2023 | 13 | 0.210 |
Why?
|
| Lipids | 1 | 2025 | 307 | 0.200 |
Why?
|
| Host-Pathogen Interactions | 2 | 2022 | 238 | 0.200 |
Why?
|
| Carbon | 1 | 2022 | 46 | 0.190 |
Why?
|
| Drug Interactions | 1 | 2022 | 113 | 0.190 |
Why?
|
| Gene-Environment Interaction | 1 | 2022 | 50 | 0.190 |
Why?
|
| Electron Transport Complex IV | 1 | 2021 | 13 | 0.190 |
Why?
|
| Drug Delivery Systems | 1 | 2025 | 311 | 0.190 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2021 | 42 | 0.180 |
Why?
|
| Immune Evasion | 1 | 2021 | 54 | 0.180 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2017 | 37 | 0.180 |
Why?
|
| Animals | 16 | 2025 | 19652 | 0.180 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2023 | 646 | 0.170 |
Why?
|
| Membrane Transport Proteins | 1 | 2020 | 120 | 0.170 |
Why?
|
| Genetic Variation | 1 | 2022 | 364 | 0.170 |
Why?
|
| Phagocytosis | 2 | 2018 | 252 | 0.160 |
Why?
|
| Cholesterol | 2 | 2017 | 255 | 0.160 |
Why?
|
| Drug Resistance, Bacterial | 3 | 2025 | 82 | 0.160 |
Why?
|
| Protein Splicing | 1 | 1998 | 3 | 0.160 |
Why?
|
| Small Molecule Libraries | 1 | 2019 | 58 | 0.160 |
Why?
|
| Genetics, Microbial | 1 | 2018 | 11 | 0.160 |
Why?
|
| Genetic Complementation Test | 1 | 1998 | 60 | 0.160 |
Why?
|
| Rec A Recombinases | 1 | 1998 | 35 | 0.150 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2019 | 183 | 0.150 |
Why?
|
| Drug Discovery | 1 | 2019 | 92 | 0.150 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2022 | 673 | 0.150 |
Why?
|
| Vaccines, Attenuated | 1 | 2018 | 35 | 0.150 |
Why?
|
| Asymmetric Cell Division | 1 | 2017 | 5 | 0.150 |
Why?
|
| NADPH Oxidase 2 | 1 | 2017 | 35 | 0.150 |
Why?
|
| Tuberculosis Vaccines | 1 | 2018 | 29 | 0.140 |
Why?
|
| Mycobacterium bovis | 1 | 2017 | 27 | 0.140 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2020 | 608 | 0.140 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2017 | 72 | 0.140 |
Why?
|
| Virulence | 6 | 2011 | 189 | 0.140 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2017 | 111 | 0.140 |
Why?
|
| N-Acetylmuramoyl-L-alanine Amidase | 1 | 2016 | 4 | 0.130 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2017 | 236 | 0.130 |
Why?
|
| Genotype | 3 | 2022 | 637 | 0.130 |
Why?
|
| Cell Cycle | 1 | 2017 | 379 | 0.130 |
Why?
|
| Adenosine Triphosphatases | 1 | 2017 | 251 | 0.120 |
Why?
|
| Phosphorylation | 5 | 2021 | 859 | 0.120 |
Why?
|
| Cytoplasm | 1 | 2016 | 273 | 0.120 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 724 | 0.120 |
Why?
|
| DNA, Recombinant | 1 | 2015 | 45 | 0.120 |
Why?
|
| Mycobacterium | 1 | 2015 | 36 | 0.120 |
Why?
|
| Gene Editing | 1 | 2018 | 301 | 0.120 |
Why?
|
| Siderophores | 2 | 2024 | 11 | 0.110 |
Why?
|
| Genetic Engineering | 1 | 2015 | 112 | 0.110 |
Why?
|
| Recombination, Genetic | 4 | 2018 | 236 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 4 | 2025 | 3193 | 0.090 |
Why?
|
| Signal Transduction | 3 | 2012 | 2887 | 0.090 |
Why?
|
| Regulon | 1 | 2010 | 6 | 0.090 |
Why?
|
| Porins | 2 | 2002 | 79 | 0.090 |
Why?
|
| Mycolic Acids | 2 | 2020 | 13 | 0.090 |
Why?
|
| Phenotype | 2 | 2022 | 1150 | 0.080 |
Why?
|
| Ligands | 2 | 2023 | 421 | 0.080 |
Why?
|
| Humans | 12 | 2025 | 59474 | 0.080 |
Why?
|
| Lung | 3 | 2025 | 833 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 3 | 2005 | 879 | 0.080 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2008 | 57 | 0.070 |
Why?
|
| Vesicular Transport Proteins | 1 | 2008 | 103 | 0.070 |
Why?
|
| Disease Models, Animal | 2 | 2025 | 2068 | 0.070 |
Why?
|
| Ethambutol | 1 | 2005 | 4 | 0.060 |
Why?
|
| Nitrites | 1 | 2005 | 9 | 0.060 |
Why?
|
| Pyrazinamide | 1 | 2025 | 7 | 0.060 |
Why?
|
| Clofazimine | 1 | 2025 | 5 | 0.060 |
Why?
|
| Linezolid | 1 | 2025 | 10 | 0.060 |
Why?
|
| Administration, Intranasal | 1 | 2025 | 27 | 0.060 |
Why?
|
| Isoniazid | 1 | 2025 | 14 | 0.060 |
Why?
|
| INDEL Mutation | 1 | 2025 | 18 | 0.060 |
Why?
|
| Genetic Fitness | 1 | 2025 | 30 | 0.060 |
Why?
|
| Disulfides | 1 | 2024 | 62 | 0.060 |
Why?
|
| Heme | 1 | 2023 | 27 | 0.060 |
Why?
|
| Phagosomes | 2 | 2017 | 44 | 0.050 |
Why?
|
| Substrate Specificity | 2 | 2019 | 322 | 0.050 |
Why?
|
| Nitrate Reductases | 1 | 2003 | 3 | 0.050 |
Why?
|
| Plasmids | 2 | 2018 | 282 | 0.050 |
Why?
|
| Repressor Proteins | 1 | 2004 | 336 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2005 | 736 | 0.050 |
Why?
|
| Peroxidases | 1 | 2001 | 7 | 0.050 |
Why?
|
| Transcription Factors | 2 | 2011 | 1457 | 0.050 |
Why?
|
| Cell Line, Tumor | 1 | 2005 | 1374 | 0.050 |
Why?
|
| DNA Damage | 1 | 2003 | 280 | 0.050 |
Why?
|
| Mutation | 3 | 2018 | 2445 | 0.050 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2021 | 130 | 0.040 |
Why?
|
| Adaptation, Physiological | 1 | 2021 | 117 | 0.040 |
Why?
|
| Threonine | 2 | 2012 | 14 | 0.040 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2020 | 177 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2001 | 281 | 0.040 |
Why?
|
| Antioxidants | 1 | 2001 | 245 | 0.040 |
Why?
|
| Topoisomerase II Inhibitors | 1 | 2019 | 9 | 0.040 |
Why?
|
| DNA Gyrase | 1 | 2019 | 8 | 0.040 |
Why?
|
| Female | 5 | 2025 | 30895 | 0.040 |
Why?
|
| Drug Resistance, Microbial | 1 | 2019 | 44 | 0.040 |
Why?
|
| Tryptophan | 1 | 2019 | 55 | 0.040 |
Why?
|
| Pandemics | 1 | 2024 | 609 | 0.040 |
Why?
|
| Folic Acid | 1 | 2019 | 58 | 0.040 |
Why?
|
| Restriction Mapping | 1 | 1998 | 53 | 0.040 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 118 | 0.040 |
Why?
|
| Genes, Bacterial | 1 | 1998 | 117 | 0.040 |
Why?
|
| Immunogenicity, Vaccine | 1 | 2018 | 7 | 0.040 |
Why?
|
| Ultraviolet Rays | 1 | 1998 | 125 | 0.040 |
Why?
|
| Protein Conformation | 1 | 2021 | 768 | 0.040 |
Why?
|
| Time-Lapse Imaging | 1 | 2017 | 17 | 0.040 |
Why?
|
| BCG Vaccine | 1 | 2018 | 43 | 0.040 |
Why?
|
| Cell Size | 1 | 2017 | 41 | 0.040 |
Why?
|
| Immunization | 1 | 2018 | 127 | 0.040 |
Why?
|
| PPAR gamma | 1 | 2017 | 73 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2017 | 71 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 2017 | 114 | 0.040 |
Why?
|
| Models, Molecular | 1 | 2021 | 1128 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2017 | 202 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2017 | 506 | 0.030 |
Why?
|
| Biological Transport | 1 | 2017 | 287 | 0.030 |
Why?
|
| Antigen Presentation | 1 | 2018 | 228 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2011 | 427 | 0.030 |
Why?
|
| Protein Domains | 1 | 2016 | 140 | 0.030 |
Why?
|
| DNA Replication | 1 | 2017 | 229 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2017 | 542 | 0.030 |
Why?
|
| Crystallography, X-Ray | 1 | 2016 | 422 | 0.030 |
Why?
|
| Autophagy | 1 | 2017 | 205 | 0.030 |
Why?
|
| Homologous Recombination | 1 | 2015 | 25 | 0.030 |
Why?
|
| Electroporation | 1 | 2015 | 32 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 1552 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2016 | 255 | 0.030 |
Why?
|
| Alleles | 1 | 2015 | 422 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 2011 | 2099 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2018 | 813 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2017 | 1988 | 0.030 |
Why?
|
| bcl-2 Homologous Antagonist-Killer Protein | 1 | 2011 | 10 | 0.020 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2011 | 23 | 0.020 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2011 | 42 | 0.020 |
Why?
|
| Cathepsins | 1 | 2011 | 32 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2011 | 104 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2011 | 137 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2011 | 197 | 0.020 |
Why?
|
| Necrosis | 1 | 2011 | 138 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2010 | 64 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2010 | 135 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2007 | 1975 | 0.020 |
Why?
|
| Protein Kinases | 1 | 2010 | 139 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2011 | 255 | 0.020 |
Why?
|
| Male | 2 | 2022 | 27561 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2011 | 316 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 525 | 0.020 |
Why?
|
| Lysosomes | 1 | 2008 | 162 | 0.020 |
Why?
|
| Serine | 1 | 2007 | 83 | 0.020 |
Why?
|
| Mutagenesis | 1 | 2007 | 130 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2007 | 385 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2007 | 353 | 0.020 |
Why?
|
| Protein Binding | 1 | 2010 | 1553 | 0.020 |
Why?
|
| Apoptosis | 1 | 2011 | 1038 | 0.020 |
Why?
|
| Computational Biology | 1 | 2007 | 327 | 0.010 |
Why?
|
| AraC Transcription Factor | 1 | 2004 | 1 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 693 | 0.010 |
Why?
|
| Base Sequence | 1 | 2007 | 1311 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2010 | 1131 | 0.010 |
Why?
|
| Bone Marrow | 1 | 2004 | 174 | 0.010 |
Why?
|
| Nitrosation | 1 | 2003 | 2 | 0.010 |
Why?
|
| Alkylation | 1 | 2003 | 11 | 0.010 |
Why?
|
| Methylnitronitrosoguanidine | 1 | 2003 | 11 | 0.010 |
Why?
|
| Nitrates | 1 | 2003 | 20 | 0.010 |
Why?
|
| Heat-Shock Response | 1 | 2002 | 35 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2007 | 685 | 0.010 |
Why?
|
| Peroxiredoxins | 1 | 2001 | 2 | 0.010 |
Why?
|
| Hydrogen Peroxide | 1 | 2001 | 74 | 0.010 |
Why?
|
| DNA, Bacterial | 1 | 2003 | 260 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2001 | 702 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1998 | 358 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1998 | 290 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1998 | 1578 | 0.010 |
Why?
|